Trevi Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2019 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Trevi Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2019 to Q3 2024.
  • Trevi Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 76.9M shares, a 20.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 76.9M +13M +20.4% Oct 31, 2024 10-Q 2024-11-06
Q2 2024 72.6M +8.74M +13.7% Jul 31, 2024 10-Q 2024-08-08
Q1 2024 69M +8.92M +14.8% Mar 20, 2024 10-K 2024-03-20
Q3 2023 63.9M +3.93M +6.57% Nov 9, 2023 10-Q 2023-11-09
Q2 2023 63.9M +21.1M +49.3% Aug 10, 2023 10-Q 2023-08-10
Q1 2023 60M +29.2M +94.9% Mar 16, 2023 10-K 2023-03-16
Q3 2022 59.9M +34.1M +132% Nov 10, 2022 10-Q 2022-11-10
Q2 2022 42.8M +21.2M +98% Aug 11, 2022 10-Q 2022-08-11
Q1 2022 30.8M +10.9M +54.7% Mar 17, 2022 10-K 2022-03-17
Q3 2021 25.8M +7.47M +40.6% Nov 10, 2021 10-Q 2021-11-10
Q2 2021 21.6M +3.36M +18.4% Aug 12, 2021 10-Q 2021-08-12
Q1 2021 19.9M +2.08M +11.7% Mar 24, 2021 10-K 2021-03-25
Q3 2020 18.4M +546K +3.06% Nov 11, 2020 10-Q 2020-11-12
Q2 2020 18.2M +406K +2.27% Aug 13, 2020 10-Q 2020-08-13
Q1 2020 17.8M Mar 13, 2020 10-K 2020-03-16
Q3 2019 17.8M Nov 14, 2019 10-Q 2019-11-14
Q2 2019 17.8M Jun 13, 2019 10-Q 2019-06-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.